Cyclerion Therapeutics, Inc.
CYCN
$2.76
$0.2158.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.01M | 3.64M | 3.23M | 2.87M | 4.59M |
| Total Receivables | 525.00K | 581.00K | 556.00K | 44.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 462.00K | 256.00K | 421.00K | 621.00K | 116.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 27.00K | 21.00K | 16.00K | 11.00K | 11.00K |
| Total Current Assets | 4.02M | 4.50M | 4.23M | 3.55M | 4.72M |
|
|
|||||
| Total Current Assets | 4.02M | 4.50M | 4.23M | 3.55M | 4.72M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 9.37M | 9.85M | 9.58M | 8.90M | 10.07M |
|
|
|||||
| Total Accounts Payable | 462.00K | 483.00K | 390.00K | 304.00K | 651.00K |
| Total Accrued Expenses | 278.00K | 539.00K | 272.00K | 353.00K | 427.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 60.00K | 45.00K | 63.00K | 43.00K | 204.00K |
| Total Other Current Liabilities | 60.00K | 45.00K | 63.00K | 43.00K | 204.00K |
| Total Current Liabilities | 800.00K | 1.07M | 725.00K | 700.00K | 1.28M |
|
|
|||||
| Total Current Liabilities | 800.00K | 1.07M | 725.00K | 700.00K | 1.28M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 800.00K | 1.07M | 725.00K | 700.00K | 1.28M |
|
|
|||||
| Common Stock & APIC | 277.82M | 277.70M | 276.34M | 276.22M | 276.08M |
| Retained Earnings | -269.25M | -268.92M | -267.49M | -268.02M | -267.30M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 8.57M | 8.78M | 8.85M | 8.20M | 8.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.57M | 8.78M | 8.85M | 8.20M | 8.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.57M | 8.78M | 8.85M | 8.20M | 8.78M |
|
|
|||||